NCT02370511 - Mitral Implantation of TRAnscatheter vaLves | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 25, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Mitral Valve Disease

Interventions

DEVICE

Transcatheter Mitral Valve Replacement

Implantation of a balloon expandable Edwards SAPIEN XT or SAPIEN 3 transcatheter heart valve in the mitral position.

Trial Locations (15)

10029

Mount Sinai Hospital, New York

10032

Columbia University Medical Center, New York

20010

MedStar Washington Medical Center, Washington D.C.

30309

Piedmont HealtCare, Atlanta

48107

Intermountain Medical Center, Murray

48202

Henry Ford Hospital, Detroit

55905

Mayo Clinic, Rochester

60201

Evanston Hospital / North Shore University HealthSystem, Evanston

77030

Memorial Hermann Texas Medical Center, Houston

85006

Banner University Medical Center, Phoenix

90048

Cedars-Sinai Medical Center, Los Angeles

98195

University of Washington Medical Center, Seattle

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors

collaborator

Henry Ford Hospital

OTHER

lead

Mayra Guerrero

OTHER